Expert consensus on clinical applications of ovarian function suppression for Chinese women with early breast cancer 2024 CACA-CBCS (China Anti-Cancer Association, Committee of Breast Cancer Society)

Title: Expert consensus on clinical applications of ovarian function suppression for Chinese women with early breast cancer 2024 CACA-CBCS (China Anti-Cancer Association, Committee of Breast Cancer Society)
Edition: Updated
Classification: Experts consensus
Field: Diagnosis and Treatment
Countries and regions: China
Guidelines users: Oncologist
Evidence classification method: The evidence level standards and recommendation grade standards of the Oxford Center for Evidence-Based Medicine in the UK are adjusted based on expert recognition.
Development unit: China Anti-Cancer Association, Committee of Breast Cancer Society
Registration time: 2024-02-19
Registration number: PREPARE-2024CN280
Purpose of the guideline: To guide clinical applications of ovarian function suppression for Chinese women with early breast cancer